CRIG and ION contribute to a white paper on cancer immunotherapy


The Biovox White Paper on Cancer Immunotherapy (download via this link) showcases innovators and world leaders in this exciting field. Besides several pharma companies, CRIG and ION (Immuno-Oncology Network) Ghent contributed by reviewing worldwide academic innovations in cancer immunotherapy, and showcasing the expertise at CRIG and ION on the topic. As the paper reaches more than 20,000 readers, this is excellent advertisement for CRIG and ION!